UBS Maintains Buy on Eastman Chemical, Lowers Price Target to $77
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
UBS analyst Joshua Spector maintains Eastman Chemical (NYSE:EMN) with a Buy and lowers the price target from $92 to $77.
UBS analyst Joshua Spector maintains Eastman Chemical (NYSE:EMN) with a Buy and lowers the price target from $92 to $77.